What Has Been The Historical And Current Growth Of The Active Implantable Medical Devices Market?
The active implantable medical devices market has seen considerable growth due to a variety of factors.
• The market for active implantable medical devices has seen robust growth in the past few years. The market, which is projected to expand from $26.19 billion in 2024 to $28.2 billion in 2025, is expected to progress at a compound annual growth rate (CAGR) of 7.7%.
Factors contributing to this growth during the historical period include robust economic progress in developing markets, augmented healthcare spending, rising occurrence of cardiovascular diseases, and expansion in the count of healthcare facilities.
What Is The Forecast For The Active Implantable Medical Devices Market By 2029?
The active implantable medical devices market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the active implantable medical devices market is projected to witness significant growth, reaching $40.3 billion in 2029 with a compound annual growth rate (CAGR) of 9.3%.
Factors contributing to this growth during the forecast period include an aging population, government backing, and the rising prevalence of neurological diseases. The forecast period will also see numerous trends including the introduction of new active implantable medical devices, strategic partnerships and collaborations, the integration of wireless technology for device charging, and the incorporation of artificial intelligence (AI) to enhance product offerings and stay competitive in the market.
What Are The Essential Drivers Behind The Growth Of The Active Implantable Medical Devices Market?
The escalating prevalence of cardiovascular disorders is predicted to boost the expansion of the active implantable medical devices market in the future. Cardiovascular disease (CVD) encompasses any disease that impinges on the heart or blood vessels, often linked with fatty deposits formation in the arteries (atherosclerosis) and an elevated risk of blood clots. Active implantable medical devices are employed to regulate or observe irregular heart rhythms in individuals diagnosed with specific heart rhythm issues or heart failure. The growth in the elderly populace has further augmented the demand for these devices. For example, a report by the American College of Cardiology in August 2022 indicated that cardiovascular risk factors are likely to escalate from 2025 to 2060, with diabetes expected to witness the highest proportional surge (a 39.3% increase to 55 million), succeeded by dyslipidemia (a 27.6% increase to 126 million), hypertension (a 25.1% rise to 162 million), and obesity (18.3% to 126 million). The study revealed that the rates of stroke (33.8% to 15 million) and heart failure (33.4% to 13 million) are anticipated to see the largest surges in cardiovascular disease rates, followed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). Thus, the proliferation in cardiovascular disorders is propelling the growth of the active implantable medical devices market.
How Is The Globa Active Implantable Medical Devices Market Divided Into Key Segments?
The active implantable medical devices market covered in this report is segmented –
1) By Product Type: Cardiac Pacemakers, Implantable Cardioverter Defibrillators (ICD), Nerve Simulators, Cochlear Implants, Ventricular Assist Devices, Other Products
2) By Application: Cardiovascular, Neurological, Hearing Impairment, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Cardiac Pacemakers: Single Chamber Pacemakers, Dual Chamber Pacemakers, Biventricular Pacemakers
2) By Implantable Cardioverter Defibrillators (ICD): Transvenous ICDs, Subcutaneous ICDs
3) By Nerve Stimulators: Spinal Cord Stimulators, Peripheral Nerve Stimulators, Deep Brain Stimulators
4) By Cochlear Implants: Single-Electrode Cochlear Implants, Multichannel Cochlear Implants
5) By Ventricular Assist Devices: Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (BiVAD)
6) By Other Products: Neurostimulators for Pain Management, Implantable Drug Delivery Systems, Implantable Blood Pressure Monitors
Pre-Book The Active Implantable Medical Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Active Implantable Medical Devices Market?
Leading firms in the active implantable medical device market are exploring product innovations, including Polyether ether ketone (PEEK) cranial implant, to gain a competitive advantage. PEEK cranial implants, being advanced healthcare devices, are used for surgical repair of cranial faults. Take for example CureTech, a medical production company based in Oman, which in April 2022, introduced their version of a Polyether ether ketone (PEEK) cranial implant. PEEK, thanks to its biocompatibility and mechanical characteristics, finds its use in a variety of implantable medical devices. This high-performance thermoplastic polymer carries attributes such as being biocompatible, radiolucent and having an elasticity modulus akin to bone, making it suitable for orthopedic applications like spinal fusion, joint replacement, and trauma surgery.
Who Are the Key Players in the Active Implantable Medical Devices Market?
Major companies operating in the active implantable medical devices market include:
• Medtronic PLC
• Boston Scientific Corporation
• Cochlear Limited
• Abbott Laboratories
• Sonova Holding AG
• MED-EL Medical Electronics
• Livanova PLC
• Biotronik Se & Co.
• Kg
• MicroPort Scientific Corporation
• Envoy Medical Corporation
• Pregna International
• Johari Digital Healthcare Limited
• Renalyx Health Systems
• Medprime Technologies
• Comofi Medtech
• Dynamed Equipments
• Aurolab
• Unicorn Denmart Limited
• Lepu Medical Technology Company
• Calon Cardio
• Better Medical Technology
• Beijing Aeonmed Co. Ltd
• BONSS MEDICAL
• Koninklijke Philips N.V.
• Berlin Heals Holding AG
• CorWave SA
• Philips Healthcare
• Draegerwerk AG
• Getinge Group
• Ceryx Medical
• MEDICO s.r.l.
• Medical-Lomza Sp. z o.o.
• Panop CZ
• Medplant LLC
• P.H.U. Medical
• ProVeterináre
• Johnson & Johnson
• Baxter
• Stryker
• Axio Biosolutions
• Cirtec Medical
• Masimo
• Teleflex Inc
• NAGL MedTech
• B Braun Argentina
• Braile Biomedica Ltd
• Megadyne Argentina
• Embramed Industria e Comercio de Produtos Hospitalares Ltd
• Arabian Medical Enterprises LLC
• Zahrawi Group
• Al Burak Medical Services
• Lodox Systems
• Glenmed Healthcare Solutions (PTY) Ltd
• Lepeke Medical Group
• LTE Medical Solutions
What are the Regional Insights into the Active Implantable Medical Devices Market?
North America was the largest region in the active implantable medical devices market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the active implantable medical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
